Tumor Recurrence After Complete Resection for Non-Small Cell Lung Cancer

被引:170
作者
Taylor, Matthew D. [1 ]
Nagji, Alykhan S. [1 ]
Bhamidipati, Castigliano M. [1 ]
Theodosakis, Nicholas [1 ]
Kozower, Benjamin D. [1 ]
Lau, Christine L. [1 ]
Jones, David R. [1 ]
机构
[1] Univ Virginia, Dept Surg, Div Thorac & Cardiovasc Surg, Charlottesville, VA 22908 USA
关键词
POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; SURVIVAL; STAGE;
D O I
10.1016/j.athoracsur.2012.03.031
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Long-term survival after R0 resection for non-small cell lung cancer (NSCLC) is less than 50%. The majority of mortality after resection is related to tumor recurrence. The purpose of this study was to identify independent perioperative and pathologic variables that are associated with NSCLC recurrence after complete surgical resection. Methods. A retrospective examination was performed of a prospectively maintained database of patients who underwent resection for NSCLC from July 1999 to August 2008 at a single institution. Clinicopathologic variables were evaluated for their influence on time to recurrence. Cox's proportional regression hazard model examined the association of recurrence in NSCLC. Results. A total of 1,143 patients met inclusion criteria and had complete follow-up information. Of these patients, 378 (33.1%) had recurrence of the primary cancer. Median follow-up was 24 months (range, 3-134 months). Preoperative tumor maximum standardized uptake value (SUVmax) greater than 5 was associated with increased risk of recurrence (hazard ratio [HR], 1.81; p = 0.01). Preoperative radiation was independently associated with recurrence (HR, 1.98; p = 0.05) as well as the presence of pathologic stage II and stage III disease (stage II: HR, 2.53; p = 0.05; stage III: HR, 6.49; p = 0.006). Subgroup analysis found that sublobar resection was also associated with locoregional recurrence after resection (HR, 4.17; p = 0.02) and lymphovascular invasion of distant recurrence (HR, 4.21; p = 0.002). Conclusions. In the largest series reported to date on postresectional recurrence of NSCLC, SUVmax greater than 5, increasing pathologic stage, and the administration of preoperative radiation were independently associated with NSCLC recurrence after resection. Sublobar resection was independently associated with locoregional recurrence, and lymphovascular invasion was associated with distant recurrence. (Ann Thorac Surg 2012;93:1813-21) (c) 2012 by The Society of Thoracic Surgeons
引用
收藏
页码:1813 / 1821
页数:9
相关论文
共 50 条
  • [21] Risk factors associated with recurrence of surgically resected node-positive non-small cell lung cancer
    Ohtaki, Yoichi
    Shimizu, Kimihiro
    Kaira, Kyoichi
    Nagashima, Toshiteru
    Obayashi, Kai
    Nakazawa, Seshiru
    Kakegawa, Seiichi
    Igai, Hitoshi
    Kamiyoshihara, Mitsuhiro
    Nishiyama, Masahiko
    Takeyoshi, Izumi
    SURGERY TODAY, 2016, 46 (10) : 1196 - 1208
  • [22] Pulmonary Resection for a Residual Tumor after Definitive Radiation in Locally Advanced Non-Small Cell Lung Cancer
    Tagawa, Tetsuzo
    Ito, Kensaku
    Fukuzawa, Kengo
    Motohiro, Akira
    THORACIC AND CARDIOVASCULAR SURGEON, 2018, 66 (02) : 170 - 173
  • [23] Ultra-late recurrence of non-small cell lung cancer over 10 years after curative resection
    Sonoda, Dai
    Matsuura, Yosuke
    Ichinose, Junji
    Nakao, Masayuki
    Ninomiya, Hironori
    Mun, Mingyon
    Ishikawa, Yuichi
    Nakagawa, Ken
    Satoh, Yukitoshi
    Okumura, Sakae
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 6765 - 6774
  • [24] Quality standards for resection of non-small cell lung cancer
    Massard, G.
    REVUE DES MALADIES RESPIRATOIRES, 2007, 24 (08) : S40 - S49
  • [25] Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study
    Wong, Melisa L.
    McMurry, Timothy L.
    Stukenborg, George J.
    Francescatti, Amanda B.
    Amato-Martz, Carla
    Schumacher, Jessica R.
    Chang, George J.
    Greenberg, Caprice C.
    Winchester, David P.
    McKellar, Daniel P.
    Walter, Louise C.
    Kozower, Benjamin D.
    LUNG CANCER, 2016, 102 : 108 - 117
  • [26] Real life adjuvant chemotherapy uptake and survival in patients with non-small cell lung cancer after complete resection
    Kolek, Vitezslav
    Losse, Stanislav
    Kultan, Juraj
    Jakubec, Petr
    Jaromir, Zatloukal
    Sova, Milan
    Szkorupa, Marek
    Neoral, Cestmir
    Skarda, Josef
    Tichy, Tomas
    Kolar, Zdenek
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (09) : 1687 - 1694
  • [27] Impact of analgesia on cancer recurrence and mortality within 5 years after stage I non-small cell lung cancer resection
    Rosboch, Giulio Luca
    Ceraolo, Edoardo
    De Domenici, Ilaria
    Guerrera, Francesco
    Balzani, Eleonora
    Lyberis, Paraskevas
    Ruffini, Enrico
    Brazzi, Luca
    TUMORI JOURNAL, 2022, 108 (04): : 364 - 370
  • [28] Sublobar Resection for Non-Small Cell Lung Cancer in Iceland
    Alexandersson, Asgeir
    Jonsson, Steinn
    Isaksson, Helgi J.
    Guobjartsson, Tomas
    LAEKNABLADID, 2011, 97 (05): : 303 - 308
  • [29] The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer
    Peters, Brandilyn A.
    Pass, Harvey, I
    Burk, Robert D.
    Xue, Xiaonan
    Goparaju, Chandra
    Sollecito, Christopher C.
    Grassi, Evan
    Segal, Leopoldo N.
    Tsay, Jun-Chieh J.
    Hayes, Richard B.
    Ahn, Jiyoung
    GENOME MEDICINE, 2022, 14 (01)
  • [30] The lung microbiome, peripheral gene expression, and recurrence-free survival after resection of stage II non-small cell lung cancer
    Brandilyn A. Peters
    Harvey I. Pass
    Robert D. Burk
    Xiaonan Xue
    Chandra Goparaju
    Christopher C. Sollecito
    Evan Grassi
    Leopoldo N. Segal
    Jun-Chieh J. Tsay
    Richard B. Hayes
    Jiyoung Ahn
    Genome Medicine, 14